Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) saw some unusual options trading on Monday. Stock traders acquired 4,016 call options on the stock. This is an increase of 229% compared to the typical volume of 1,222 call options.
Analyst Ratings Changes
Several equities analysts have weighed in on PURR shares. Cantor Fitzgerald raised Hyperliquid Strategies to a “strong-buy” rating in a research report on Thursday, April 9th. Wall Street Zen raised Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Weiss Ratings started coverage on Hyperliquid Strategies in a research report on Monday, March 2nd. They issued a “sell (e)” rating for the company. Finally, Chardan Capital lifted their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $7.23.
Check Out Our Latest Report on PURR
Hedge Funds Weigh In On Hyperliquid Strategies
Hyperliquid Strategies Stock Performance
Shares of Hyperliquid Strategies stock opened at $6.50 on Tuesday. Hyperliquid Strategies has a one year low of $3.01 and a one year high of $6.63. The firm has a market capitalization of $805.81 million, a P/E ratio of -0.70 and a beta of 1.38. The stock’s 50-day moving average is $4.96.
Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) last announced its quarterly earnings data on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter. The firm had revenue of $0.50 million during the quarter.
Hyperliquid Strategies Company Profile
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Recommended Stories
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
